Evidence map›Paper›PMID 21151658›Full record

ArticleJournal of nucleic acids2010

Aflatoxin B(1)-Associated DNA Adducts Stall S Phase and Stimulate Rad51 foci in Saccharomyces cerevisiae.

Michael Fasullo, Yifan Chen, William Bortcosh, Minzeng Sun, Patricia A Egner

Open access · goldAbstract read
In one paragraph

Article in Journal of nucleic acids, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Genome Profiling for Aflatoxin BG3 (Bethesda, Md.) · 2020
    Article
  3. Review
  4. TheFrontiers in microbiology · 2019
    Review
  5. Article
  6. Article
  7. Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae.Mutation research. Genetic toxicology and environmental mutagenesis · 2014
    Article
  8. CYP1B1 converts procarcinogens into genotoxins in Saccharomyces cerevisiae.Mutation research. Genetic toxicology and environmental mutagenesis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Michael FasulloOrdway Research Institute, Center for Medical Sciences, 150 New Scotland Avenue, Albany, NY 12209, USA.
Yifan Chen
William Bortcosh
Minzeng Sun
Patricia A Egner
Research Medical Center · USAlbany Medical Center Hospital · USJohns Hopkins University · USUniversity at Albany, State University of New York · US

Funding

Validation and Application of Risk, Biomarkers in Human StudiesP01ES006052 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI GROOPMAN, JOHN D · 1993 to 2012
$22.6M
Activating liver carcinogens in yeast by expressing CYP450 polymorphismsR21ES015954 · NIEHS · ORDWAY RESEARCH INSTITUTE, INC. · PI FASULLO, MICHAEL THOMAS · 2007 to 2010
$742k
NIEHS NIH HHS P01 ES006052NIEHS NIH HHS R21 ES015954
6 · The paper itself

Abstract

AFB(1) is a potent recombinagen in budding yeast. AFB(1) exposure induces RAD51 expression and triggers Rad53 activation in yeast cells that express human CYP1A2. It was unknown, however, when and if Rad51 foci appear. Herein, we show that Rad53 activation correlates with cell-cycle delay in yeast and the subsequent formation of Rad51 foci. In contrast to cells exposed to X-rays, in which Rad51 foci appear exclusively in G2 cells, Rad51 foci in AFB(1)-exposed cells can appear as soon as cells enter S phase. Although rad51 and rad4 mutants are mildly sensitive to AFB(1), chronic exposure of the NER deficient rad4 cells to AFB(1) leads to increased lag times, while rad4 rad51 double mutants exhibit synergistic sensitivity and do not grow when exposed to 50 μM AFB(1). We suggest RAD51 functions to facilitate DNA replication after replication fork stalling or collapse in AFB(1)-exposed cells.

Identifiers

PMID21151658
PMCPMC2997344
OpenAlexW2011405454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.